Inventor · disambiguated record
Sara Schumann
Also filed as: SCHUMANN SARA
0 granted patents·9 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
9 records- 0159US2025064801A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of congenital muscular dystrophiesMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0259US2025064800A1Combination of budesonide and 5-amino-2,3-dihydro-1,4-phthalazinedioneMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0355US2025032486A1Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a 6'-methoxycinchonan-9-ol for use in the treatment of coronaviral infectionsMETROPHARM AG·Filed 2022·Application pending·0 cites
- 0451US2023241060A1Glucocorticoid-sparing agentMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 0549US2023218614A1Compound for the treatment of coronaviral infectionsMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 0648US2023113516A15-amino-2,3-dihydro-1,4-phthalazinedione for treatment of acute lung injuryMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 0747US2023053455A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseasesMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 0846US2023061223A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmonary diseasesMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 0940US2024075029A1Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infectionMETRIOPHARM AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sara Schumann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →